Financial News · Live Terminal

Page 3 of 170

Research Alert: CFRA Keeps Hold Opinion On Shares Of Realty Income Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our price target by $3 to $67, implying 15.2x our 2026 FFO estimate, a premium to O's three-year average multiple of 13.6x as the outlook for lower borrowing costs and improving yields in the U.K. is likely to support higher FFO growth. We decrease our 2026 FFO estimate by $0.02 to $4.42 and increase 2027 by $0.04 to $4.59. O continued to invest heavily in Europe and the U.K. in Q1, totaling $1.0B of the $2.8B in total investments, while remaining disciplined as management closed on just 9% of the $31B in opportunities it sourced. O has also moved into the private market with strategic partnerships, a $1B JV fund with Apollo, and its $1.7B capital raise for its Perpetual Life U.S. Core+ fund. We believe this increases its TAM and opens the door for larger private fund opportunities. Despite the increased acquisition pace, we note net debt-to-EBITDA at 5.2x leaves room for further large-scale activity this year while total debt carries only a 4.34% blended rate.

Research21h ago

Research Alert: CFRA Reiterates Buy Rating On Nyse Shares Of Brookfield Asset Management Ltd.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target price at $60 applying a forward P/E of 31.5x compared to the three-year historical average at 30.2x. Our valuation is supported by our view on growth of the business, diversification in high quality markets, and the durability of earnings. We raise our 2026 distributed earnings per share by $0.10 to $1.90 and increase 2027 by $0.10 to $2.25, both near consensus estimates. Compared to ALT peers that trade in the 20x-30x range, our premium valuation for BAM is based on its global leadership with diversified investments and performance track record. The firm has been handling infrastructure investing for decades and stands to benefit from AI-related investments in power, transmission, and data centers. Electricity and power are a key areas for AI infrastructure. We think BAM is best positioned for this opportunity. The market environment across all business segments remains strong, in our view. We see healthy fundraising and monetization, and the dividend yield is 3.25%.

$BAM

Research21h ago

Research Alert: CFRA Reiterates Buy Opinion On Tsx Shares Of Brookfield Asset Management Ltd.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target at CAD82 applying a forward P/E of 31.5x compared to the three-year historical average at 30.2x. Our valuation is supported by our view on growth of the business, diversification in high quality markets, and the durability of earnings. We raise our 2026 distributed earnings per share by $0.10 to $1.90 and increase 2027 by $0.10 to $2.25, both near consensus estimates. Compared to ALT peers that trade in the 20x-30x range, our premium valuation for BAM is based on its global leadership with diversified investments and performance track record. The firm has been handling infrastructure investing for decades and stands to benefit from AI-related investments in power, transmission, and data centers. Electricity and power are a key areas for AI infrastructure. We think BAM is best positioned for this opportunity. The market environment across all business segments remains strong, in our view. We see healthy fundraising and monetization, and the TSX shares' dividend yield is 4.11%.

$BAM

Research21h ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of The Goodyear Tire & Rubber Company

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We cut our 12-month target by $3 to $7, based on a 2027 P/E of 10.0x, a steep but justified discount to Goodyear's 10-year mean forward P/E of 13.5x. We lower our adjusted EPS estimates to $0.25 from $1.00 for '26 and to $0.70 from $1.40 for '27. Goodyear posted Q1 adjusted EPS of -$0.39 vs. -$0.04, ahead of the -$0.43 consensus. The beat was due to stronger-than-expected sales, as revenue fell 8.7% to $3.88B ($70M ahead of consensus) on an 11.6% drop in tire sales volume, partially offset by higher prices. The segment operating margin contracted 220 bps to 2.4%. Looking ahead, management said it expects increased pressure on tire industry demand and higher raw material costs stemming from Middle East conflict. Goodyear continues to face demand-related issues and the recent spike in crude oil prices should equate to meaningful pressures on profitability, as approximately two-thirds of Goodyear's raw materials costs are petroleum-based (and it doesn't hedge commodity prices). We remain at a Hold on the shares.

$GT

Research21h ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of Valvoline Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month target of $38, based on a P/E of 17.3x our FY 27 (Sep.) EPS estimate, a justified discount to the stock's 10-year average forward P/E of 19.2x. Following VVV's earnings release, we are maintaining our estimates and our Hold opinion on the shares. Our adjusted EPS estimates remain $1.80 for FY 26 and $2.20 for FY 27. VVV posted Q2 FY 26 (Mar.) adjusted EPS of $0.41 vs. $0.34 (+21%), well ahead of the $0.34 consensus. Revenue rose 25% to $504M ($9M above consensus), and adjusted EBITDA margin expanded 60 bps to 26.5% (160 bps ahead of consensus). VVV's top-line growth should accelerate to 21% in FY 26 (vs. 6% in FY 25), driven by 162 net new stores added through its acquisition of Breeze AutoCare on December 1, 2025 (for $593M) plus SSS growth of approximately 6%. SSS growth is benefiting from a record-high average U.S. vehicle fleet, which is increasing maintenance frequency. Still, we view the stock's valuation as fair, preferring other names in the auto retail space.

$VVV

Research22h ago

Research Alert: CFRA Maintains Hold Rating On Shares Of Medline Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month price target of $46 (lowered from $52) is 27.7x our 2027 EPS estimate, a small discount to the 28.4x forward average since the recent IPO. Our 2026 EPS estimate is $1.50 (up from $1.47), while our 2027 EPS estimate is $1.60 (down from $1.65). We look favorably on MDLN raising 2026 sales growth expectations despite looming headwinds facing the industry, supported by customer growth, including a new Prime Vendor signing with Mohwak Medbuy Corporation (serving nine acute care hospitals) in Canada. Looking ahead, MDLN sees reimbursement cuts and insurance coverage losses, stemming from recent policy developments such as the expiration of ACA enhanced premium tax credits and the passage of the One Big Beautiful Bill Act, which may cause moderation in healthcare utilization during 2H 2026. We also anticipate margin pressure from inflationary fuel, plastics, and other material costs. We maintain our Hold rating.

$MDLN

Research22h ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of The Clorox Company

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price is $112 (down from $121 on May 7), 20x our FY 26 view of $5.60. Our multiple is a discount to the 22.2x three-year average forward P/E, reflecting CLX's recent dynamic performance such as disruptions and portfolio restructuring amid a softening demand environment. We lower our FY 26 EPS estimate by $0.30 to $5.60 and FY 27 by $0.52 to $6.25. CLX reported Q3 fiscal 2026 results that reflected a mixed operating environment, with net sales of $1.67B (in line with estimates) flat vs. the prior year. EPS grew 13% to $1.64 from $1.45, $0.10 above consensus. Household and International segments delivered solid growth of 3% and 8%, respectively, while the Lifestyle segment contracted 9% on lower consumption and retail inventory adjustments. Health and Wellness sales held steady with volume gains being offset by unfavorable price/mix dynamics. Gross margin compressed 140 bps to 43.2% from 44.6% in the prior year due to elevated manufacturing and logistics costs.

$CLX

Research22h ago

Research Alert: Tou Maintained Buy As Lower Gas Pricing Dents Cash Flow: Tp Cad74

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our Buy (4-STARS) rating and decrease our target price to CAD74. This is based on an EV/EBITDA multiple of 6.8x our 2027 EBITDA projection. We reduced the EBITDA multiple from 7.2x to 6.8x to bring it closer in line with the long-term bands. While still a premium multiple, we believe the Iranian war, ARC deal, and global energy sentiment will elevate multiples for a time. Q1 production was 666,089 boe/d, within guidance. Cash flow declined 10% to CAD862.2M, reflecting lower gas pricing realizations, which were down 17% Y/Y. Overall, guidance was maintained and infrastructure projects remain on schedule. No special dividend or base dividend increase was announced.

$TOU

Research22h ago

BofA Securities Downgrades Planet Fitness to Neutral From Buy, Price Target is $59

Planet Fitness (PLNT) has an average rating of overweight and mean price target of $78.39, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $45.52, Change: $+1.51, Percent Change: +3.43%

$PLNT

Research22h ago

Research Alert: CFRA Raises Rating On Itt Shares To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target following Q1 results to $250 from $220, valuing shares at 27x our 2027 EPS outlook of $9.27 (up from $8.15; 2026 EPS forecast revised to $7.95 from $7.46), above ITT's long-term historical average given portfolio optimization toward high-growth markets. The integration of SPX FLOW, which closed in March, accounted for a significant portion of the top-line expansion (up 33% Y/Y) and was immediately accretive to adjusted earnings per share - even after accounting for initial acquisition-related costs and financing. We are encouraged by ITT's early results in integrating SPX FLOW, with $15M of cost synergies expected by year-end. Underlying organic performance was driven by sustained strength in aerospace and defense within the CCT segment, share gains in Motion Tech that outpaced a declining automotive market, and robust project and short-cycle activity in the legacy Flow Tech business.

$ITT

Research22h ago

Research Alert: CFRA Lowers Opinion On Ads Of Toyota Motor Corporation To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price to USD150 from USD260, implying a FY 27 (Mar.) P/B of 0.72x, as the latest financial reports and guidance confirm that the structural profit erosion is deeper and more prolonged than we previously anticipated. Our revised FY 27 EPS estimate of JPY2,830, reduced from JPY3,330, reflects the incremental headwind from the Middle East that management has acknowledged it cannot fully absorb on top of the persistent U.S. tariff burden. We initiate a FY 28 EPS forecast of JPY3,210, assuming some degree of stabilization in tariff and geopolitical conditions and a gradual benefit from cost-reduction and value-chain initiatives, but still well short of the levels that would support the previous valuation premium. Our de-rating reflects not only the immediate compression in earnings but also the heightened unpredictability of trade policy and the risk that Toyota's break-even volume remains structurally elevated. We downgrade our rating to Sell from Hold.

$TM

Research22h ago

Research Alert: CFRA Keeps Buy Opinion On Shares Of Willis Towers Watson

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $80 to $300, valuing WTW at 13.5x our '27 adjusted EPS estimate of $22.20 (lowered by $0.20), and at 15.4x our '26 EPS estimate of $19.52 (trimmed by $0.18), versus its one-year avg. forward multiple of 17x and disparate peer group average of 15x. WTW posted Q1 2026 EPS of $3.72 vs. $3.13 in the prior year, beating the $3.65 consensus but missing our $3.85 estimate, though the results reflected continued turnaround progress. Revenue rose 8% to $2.4B, with 3% organic growth demonstrating solid business momentum despite macroeconomic headwinds, while adjusted operating margin expanded 70 bps to 22.3%, reflecting transformation program benefits and disciplined expense management. We are encouraged by the results and WTW's operational discipline, though more competitive conditions may crimp organic revenue growth. We see the current AI-driven fears as overdone. Currently trading at 13x our '26 EPS estimate, a discount to peer and historical averages, we view WTW as undervalued.

$WTW

Research22h ago

Research Alert: CFRA Upgrades View On Shares Of Cummins Inc. To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target to $850 from $600 following CMI's Q1 earnings print, valuing shares at 25.7x our 2027 EPS view of $33.09 (up from $30.00; 2026 EPS forecast revised to $27.51 from $26.47), above the company's historical multiple average given profitable exposure to power generation markets that we see being a multi-year structural tailwind. Q1 results were supported by CMI's power generation business, which is being driven by robust global demand, particularly from data centers. This growth is helping to offset a weaker, though improving, environment in the on-highway truck markets, which appear to be recovering from a cyclical trough sooner than previously anticipated. In parallel, CMI is undertaking strategic actions to improve the growth trajectory of its new power segment by divesting from less promising areas. Q1 performance contributed to an increase in the full-year forecast for both revenue and profitability.

$CMI

Research23h ago

Research Alert: CFRA Maintains Hold Rating On Shares Of Jack Henry & Associates, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $35 to $160, 22.3x our FY 27 (Jun.) EPS estimate, above peers, reflecting JKHY's resilient recurring revenue business model. We increase our FY 26 EPS view by $0.15 to $6.84 and FY 27's by $0.19 to $7.19 on respective revenue forecasts of $2.53B (+7%) and $2.68B (+6%). Bolstered by its strongest Mar-Q for new core wins in seven years (17 competitive core wins), JKHY raised its full-year fiscal 2026 guidance for both revenue and EPS. We think momentum will be fueled by significant traction in new SMB-focused solutions like Tap2Local and tangible productivity gains from internal AI initiatives. Management expressed high confidence in capitalizing on competitor uncertainty, positioning the company for sustained market share gains in the evolving financial technology landscape. While the company guided for a softer fourth quarter due to expense timing and tougher comparisons, the primary challenge ahead will be successfully executing on the large influx of new business.

$JKHY

Research23h ago

JPMorgan Initiates Coverage on CEVA With Neutral Rating, $30 Price Target

CEVA (CEVA) has an average rating of buy and mean price target of $32.71, according to analysts polled by FactSet.Price: $35.07, Change: $+1.35, Percent Change: +4.00%

$CEVA

Research23h ago

Research Alert: Wsp Maintained At Buy On Trc Integration And Ebitda Margin Expansion: Tp Cad271

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our Buy (4-STARS) rating on WSP, as it trades at historic discounts on a forward earnings and EBITDA basis. We reduced our target price to CAD271 from CAD283. We value WSP at an average of 13x our 2027 EBITDA estimate and 22x our 2027 EPS view. We increase our 2026 adjusted EPS forecast to CAD11.31 (up by CAD0.20) and our 2027 adjusted EPS estimate to CAD12.02 (up by CAD0.21). Both multiples are currently under the lower band relative to the peer group by 2.2-2.8 standard deviations. We consider the valuation to be a buying opportunity on a company that is expanding its EBITDA margin continually and growing inorganically. Additionally, we are encouraged by the growing impact the U.S. Power & Energy segment has on the direction of the business, with ~30% of U.S. revenues.

$WSP

Research23h ago

Research Alert: Paa: Slight Miss In Q1, Strategic Repositioning Almost Complete

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PAA posted Q1 adjusted earnings per unit of $0.39, missing consensus by $0.03, with adjusted EBITDA of $730M down 3% Y/Y. The Crude Oil segment generated adjusted EBITDA of $582M, up 4% Y/Y, driven by Permian volumes up 10.5%, while the NGL segment declined 23% to $145M due to lower frac spreads and reduced sales volumes. The mixed results highlight PAA's strategic repositioning toward crude oil focus through the pending Canadian NGL divestiture to Keyera. Management raised CY26 adjusted EBITDA guidance to approximately $2.88B, with the midpoint up $130M or 4.7%. We expect the Keyera deal, fetching ~$3.75B in cash and closing this month, will help address balance sheet concerns as pro forma leverage of 4.1x remains above PAA's target range of 3.25x-3.75x. The strategic repositioning should make PAA a more purely crude oil-focused midstream play while proceeds enable debt reduction from the current $11.6B net debt level.

$PAA

Research23h ago

Ameriprise Downgrades Zoetis to Hold From Buy

Zoetis (ZTS) has an average rating of overweight and mean price target of $135, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $83.81, Change: $-3.50, Percent Change: -4.01%

$ZTS

Research23h ago

Research Alert: CFRA Keeps Sell Opinion On Shares Of American Homes 4 Rent

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our $27 target using a forward P/FFO of 13.8x, factoring in lower FFO growth in 2026-2027. We keep our FFO estimates unchanged at $1.95 in 2026 and $2.05 in 2027 on projected revenue of $1.9B and $2.0B, respectively. AMH faces mounting operational headwinds from elevated housing supply and negative new lease spreads, compounded by heightened regulatory scrutiny that introduces material policy risk to the single-family rental business model. AMH has capital allocation focused on share repurchases, given the challenging acquisition environment, with $406.0M remaining authorization under new $500M program. Full-year FFO guidance maintained at 1.1%-4.3%, reflecting management's cautious outlook amid operational headwinds. Given same-store operating expense growth exceeding operating revenue growth, we are expecting cash NOI growth to remain near 1%-2% Y/Y in 2026. We believe economic uncertainty regarding U.S. job growth and affordability for single-family homes for rent present constraints on AMH growth.

$AMH

Research23h ago

Research Alert: CFRA Maintains Buy Opinion On Shares Of Loblaw Companies Limited

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target to CAD69 from CAD74, representing ~24x our 2027 EPS of CAD2.88 (lowered from CAD2.95; 2026 EPS lowered to CAD2.61 from CAD2.66). This multiple represents a premium to the company's five-year average forward P/E of 18x, though we note L traded above 20x in the early 2000s. We believe this premium is justified given strong top- and bottom-line growth. Additionally, L has accelerated new store openings (both food and drug retail) in recent years, which should increasingly contribute to revenue as these locations mature. The current earnings headwind from the East Gwillimbury distribution center ramp should ease later this year, though a similar drag is likely as the new Caledon distribution center ramps in 2027. Nevertheless, L is positioned to deliver impressive high-single digit EPS growth over the next few years. We also anticipate a sizable share buyback following the PC Financial sale closure in Q3.

Showing 41-60 of 3396